Epilepsy in Adults with Mitochondrial Disease: A Cohort Study
Ann Neurol 78:949-957, Whittaker, R.G.,et al, 2015
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Status Epilepticus Migrainosus: Clinical, Electrophysiologic, and Imaging Characteristics
Neurol 75:373-374, Perucca,P., et al, 2010
MELAS Syndrome:Characteristic Migrainous & Epileptic Features and Maternal Transmission
Neurol 38:751-754, Montagne,P.,et al, 1988
Neurologic Disorders in Renal Failure (1st of Two Parts)
NEJM 294:143, Raskin,N.H.,et al, 1976
Ictal Amaurosis:MRI, EEG, and Clinical Features
Neurol 45:1619-1621, Gilliam,F.&Wyllie,E., 1995
Episodic Disorders of Vision
MCV Quart 12:99-109, Harbison,J.W., 1976
Genetic Causes of Cerebral Small Vessel Diseases, A Parctical Guide for Neurologists
Neurol 100:766-783, Manini,A.,&Pantoni,L., 2023
Migraine, hearing loss, and blurred vision in a young woman
Neurol 95:e2945-e2950, Sasikumar, S.,et al, 2020
Cyclic Vomiting Syndrome in Children
AJGH 2:doi:10.33552/AJGH.2020, Al-Ansari, N., 2020
Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients
Stroke 50:283-290, Drazyk, A.M.,et al, 2019
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations
AJNR 37:774-781, Winton-Brown, T.T.,et al, 2016
Stroke and NonStroke Brain Attacks in Children
Neurol 82:1434-1440, Mackay, M.T.,et al, 2014
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Clinical Spectrum of CADASIL and the Effect of Cardiovascular Risk Factors on Phenotype: Study in 200 Consecutively Recruited Individuals
Stroke 41:630-634, Adib-Samii,P., et al, 2010
Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts & Leukoencephalopathy (CADASIL)
UpToDate (www.uptodate.com) Aug 21, Dichgans,M.,et al., 2007
Primary Episodic Ataxias:Diagnosis, Pathogenesis and Treatment
Brain 130:2484-2493, Jen, J.C.,et al, 2007
Mitochondrial DNA Polymerase-y and Human Disease
Hum Mol Genet 15:R244-R252, Hudson, G.,et al, 2006
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
"CADASIL Coma"" An Underdiagnosed Acute Encephalopathy
JNNP 74:249-252, Schon,F.,et al, 2003
The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Acetazolamide Treatment for Migraine Aura Status
Neurol 55:1588-1589, Haan,J.,et al, 2000
Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999
Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999
Migraine and Reduced Work Performance, A Population-Based Diary Study
Neurol 50:1741-1745, Von Korff,M.,et al, 1998
A Placebo-ControlledCrossover Study of Rizatriptan in the Treatment of Multiple Migraine Attacks
Neurol 52:773-781, Kramer,M.S.,et al, 1998
Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997
Safety and Efficacy of Ergotamine Tartrate & Dihydroergotamine in the Trmt of Migraine & Status Migrainosus
Neurol 45:577-584, Silberstein,S.D.,et al, 1995
Practice Parameter:Appropriate Use of Ergotamine Tartrate & Dihydroergotamine in the Trmt of Migraine & Status Migrainosus
Neurol 45:585-587, , 1995
Conditions That Mimic Stroke in the Emergency Department
Arch Neurol 52:1119-1122, Libman,R.B.,et al, 1995
Alternating Hemiplegia of Childhood:A Study of 10 Pts & Results of Flunarizine Treatment
Neurol 43:36-41, Silver,K.&Andermann,F., 1993
Classical Migraine:Symptoms Between Visual Aura and Headache Onset
Lancet 340:355-356, Blau,J.N., 1992
Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992
Recurrent Prolonged Coma Due to Basilar Artery Migraine:A Case Report
Headache 31:75-81, Frequin,S.T.F.M.,et al, 1991
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Migraine Assoc with Focal Cerebral Edema, CSF Pleocytosis, & Prog Cerebellar Ataxia:MRI Documentation
Neurol 40:1284-1287, Goldstein,J.M.,et al, 1990
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Randomized Double-Blind Trial of Intravenous Prochlorperazine for the Treatment of Acute Headache
JAMA 261:1174-1176, Jones,J.,et al, 1989
An Epidemiologic Study of Headache Among Adolescents and Young Adults
JAMA 261:2211-2216, Linet,M.S.,et al, 1989
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Repetitive Intravenous Dihydroergotamine as Therapy for Intractable Migraine
Neurol 36:995-997, Raskin,N.H., 1986